Nonmelanoma Skin Cancer Risk With JAK Inhibitors Compared to Interleukin‐6 Receptor Inhibitors in Rheumatoid Arthritis: Results From a National Cohort Study

Study limitation reported by the research below: “IPTW adjusts for measured confounders only; unmeasured confounding (e.g., UV exposure, skin cancer screening frequency) cannot be ruled out.”